BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 27
• 28
• 29
• 30
• 31

• Business

  iTeos Reports First Quarter 2024 Financial Results and Provides Business Updates

  iTeos Therapeutics, Inc. (Nasdaq: ITOS), a clinical-stage biopharmaceutical company pioneering the discovery and development of a new generation of immuno-oncology therapeutics for patients, today reported financial results for the first quarter ended March 31, 2024 and provided a business update.

  May 10, 2024

   · 

  11 min read
• Orexo publishes prospectus and applies for admission to trading of social bonds on Nasdaq Stockholm

  On March 28, 2024, Orexo AB, successfully issued senior secured callable floating rate social bonds in an amount of SEK 500 million and with a tenor of four years.

  May 10, 2024

   · 

  2 min read
• Pharm Country

  CorMedix Inc. to Participate in Two Upcoming Investor Conferences - May 10, 2024

  CorMedix Inc. today announced that management will be participating in fireside chats and investor meetings at both the JMP Securities Life Sciences Conference being held in New York on May 13 – 14, 2024 and the 2024 RBC Capital Markets Global Healthcare Conference being held in New York.

  May 10, 2024

   · 

  1 min read
• Business

  Checkpoint Therapeutics Reports First Quarter 2024 Financial Results and Recent Corporate Updates

  Checkpoint Therapeutics, Inc. today announced financial results for the first quarter ended March 31, 2024, and recent corporate updates.

  May 10, 2024

   · 

  9 min read
• Pharm Country

  Citius Pharmaceuticals to Participate in Upcoming EF Hutton and H.C. Wainwright Investor Conferences

  Citius Pharmaceuticals, Inc. today announced its participation in two upcoming investor conferences.

  May 10, 2024

   · 

  2 min read
• Business

  Xenetic Biosciences, Inc. Reports First Quarter 2024 Financial Results and Provides Business Update

  Xenetic Biosciences, Inc. today reported its financial results for the first quarter of 2024 and provided a business update.

  May 10, 2024

   · 

  6 min read
• Business

  Omeros Corporation to Announce First Quarter Financial Results on May 15, 2024

  Omeros Corporation (NASDAQ: OMER), today announced that the company will issue its financial results for the quarter and year ended March 31, 2024, on Wednesday, May 15, 2024, after the market closes.

  May 10, 2024

   · 

  2 min read
• Biotech Beach

  Artelo Biosciences to Present at the Pharma Partnering Summit 2024 on May 14th

  Artelo Biosciences, Inc. today announced that it will be participating in the 2024 Pharma Partnering Summit being held May 14th – 15th in San Diego, California.

  May 10, 2024

   · 

  3 min read
• Business

  Helius Medical Technologies, Inc. to Release First Quarter 2024 Financial Results on May 13, 2024

  Helius Medical Technologies, Inc. today announced that the Company will release its first quarter 2024 financial results on Monday, May 13, 2024, after the market closes.

  May 10, 2024

   · 

  2 min read
• Business

  James Brodie of Johnson & Johnson MedTech Appointed Chair of the Medtech Canada Board of Directors

  Medtech Canada is very pleased to welcome James Brodie of Johnson & Johnson MedTech as Chair of the Medtech Canada Board of Directors.

  May 10, 2024

   · 

  3 min read